Literature DB >> 33158737

E.U. paediatric MOG consortium consensus: Part 2 - Neuroimaging features of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders.

Matthias Baumann1, Frederik Bartels2, Carsten Finke2, Catherine Adamsbaum3, Yael Hacohen4, Kevin Rostásy5.   

Abstract

Imaging plays a crucial role in differentiating the spectrum of paediatric acquired demyelinating syndromes (ADS), which apart from myelin oligodendrocyte glycoprotein antibody associated disorders (MOGAD) includes paediatric multiple sclerosis (MS), aquaporin-4 antibody neuromyelitis optica spectrum disorders (NMOSD) and unclassified patients with both monophasic and relapsing ADS. In contrast to the imaging characteristics of children with MS, children with MOGAD present with diverse imaging patterns which correlate with the main demyelinating phenotypes as well as age at presentation. In this review we describe the common neuroradiological features of children with MOGAD such as acute disseminated encephalomyelitis, optic neuritis, transverse myelitis, AQP4 negative NMOSD. In addition, we report newly recognized presentations also associated with MOG-ab such as the 'leukodystophy-like' phenotype and autoimmune encephalitis with predominant involvement of cortical and deep grey matter structures. We further delineate the features, which may help to distinguish MOGAD from other ADS and discuss the future role of MR-imaging in regards to treatment decisions and prognosis in children with MOGAD. Finally, we propose an MRI protocol for routine examination and discuss new imaging techniques, which may help to better understand the neurobiology of MOGAD.
Copyright © 2020 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ADEM; MOG; MRI; Optic neuritis; Paediatrics; Transverse myelitis

Mesh:

Substances:

Year:  2020        PMID: 33158737     DOI: 10.1016/j.ejpn.2020.10.002

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  6 in total

1.  High titers of myelin oligodendrocyte glycoprotein antibody are only observed close to clinical events in pediatrics.

Authors:  Allysa Lui; Janet Chong; Eoin Flanagan; Aaron W Abrams; Kristen M Krysko; Burak Arikan; Carla Francisco; Alice Rutatangwa; Emmanuelle Waubant; Amin Ziaei
Journal:  Mult Scler Relat Disord       Date:  2021-09-04       Impact factor: 4.339

Review 2.  Myelin Oligodendrocyte Glycoprotein-Associated Disorders.

Authors:  Erin Longbrake
Journal:  Continuum (Minneap Minn)       Date:  2022-08-01

3.  Clinical and Magnetic Resonance Imaging Characteristics of Pediatric Acute Disseminating Encephalomyelitis With and Without Antibodies to Myelin Oligodendrocyte Glycoprotein.

Authors:  Meifang Lei; Yaqiong Cui; Zhaoying Dong; Xiufang Zhi; Jianbo Shu; Chunquan Cai; Dong Li
Journal:  Front Pediatr       Date:  2022-05-20       Impact factor: 3.569

Review 4.  [Acute disseminated encephalomyelitis].

Authors:  Malgorzata Wolska-Krawczyk
Journal:  Radiologe       Date:  2022-03-15       Impact factor: 0.803

Review 5.  Multiple Sclerosis in Children: Differential Diagnosis, Prognosis, and Disease-Modifying Treatment.

Authors:  Dejan Jakimovski; Samreen Awan; Svetlana P Eckert; Osman Farooq; Bianca Weinstock-Guttman
Journal:  CNS Drugs       Date:  2021-12-23       Impact factor: 5.749

Review 6.  Clinical and neuroimaging findings in MOGAD-MRI and OCT.

Authors:  Frederik Bartels; Angelo Lu; Frederike Cosima Oertel; Carsten Finke; Friedemann Paul; Claudia Chien
Journal:  Clin Exp Immunol       Date:  2021-07-18       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.